Peginterferon alfa-2b biosimilars (Bio-Ker)

聚乙二醇干扰素α-2b生物类似药 (Bio-Ker)

Report date: 2022/01/24 13:25:21

Base Information

Drug NamePeginterferon alfa-2b biosimilars (Bio-Ker)
Drug Alias Name聚乙二醇干扰素α-2b生物仿制药 (Bio-Ker)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBio-Ker Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio-Ker Srl
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeL03AB10
Related LinksN/A